Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017

Details for Mechanism ID: 17600
Country/Region: Indonesia
Year: 2016
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $5,239,394 Additional Pipeline Funding: $339,682

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $404,341
Care: TB/HIV (HVTB) $202,170
Strategic Information (HVSI) $285,000
Health Systems Strengthening (OHSS) $108,119
Testing: HIV Testing and Counseling (HVCT) $583,591
Sexual Prevention: Other Sexual Prevention (HVOP) $1,846,421
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $91,123
Treatment: Adult Treatment (HTXS) $1,718,629
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 22,285
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 6,475
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 55
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 27
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 79
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 17
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,037
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 495
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,542
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 326
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 194
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 12,084
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 210
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 1,890
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 4,300
KP_PREV By key population type: Transgender who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 1,200
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 194
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 23,664
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 16,468
PP_PREV Total number of people in the target population 2017 50,000
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 53
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 214
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 92
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 182
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 3,598
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 3,266
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,325
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,924
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,325
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,924
TX_CURR Aggregated Age/Sex: <15 Female 2017 78
TX_CURR Aggregated Age/Sex: <15 Female 2017 98
TX_CURR Aggregated Age/Sex: <15 Male 2017 104
TX_CURR Aggregated Age/Sex: <15 Male 2017 66
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,468
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,865
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,947
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,240
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 3,598
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 3,266
TX_CURR Sum of Aggregated Age/Sex <15 2017 182
TX_CURR Sum of Aggregated Age/Sex <15 2017 164
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 3,415
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 3,105
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 3,597
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 3,269
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 11
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 8
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 6
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 8
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 207
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 160
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 110
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 136
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,021
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,596
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 362
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 284
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,174
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 919
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,562
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,159
Cross Cutting Budget Categories and Known Amounts Total: $2,995,815
Key Populations: MSM and TG $1,115,815
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Key Populations: Sex Workers $400,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Gender: Gender Based Violence (GBV) $780,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $500,000
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Condoms: Policy, Tools, and Services $200,000